Company intelligence / Profile preview

LabCentral

Cambridge, Massachusetts, United Stateslabcentral.org ↗

Ownership: Private
Development stage: Other

Overview

LabCentral provides shared laboratory and office space, operational support, and community programming to early-stage life sciences and biotech startups. Its resident companies have collectively started 30 new clinical trials in 2024 alone—including seven therapies in Phase 3 studies—and have raised over $20 billion since inception. The organization plays a pivotal role in accelerating innovation by enabling startups to focus on science rather than infrastructure.

Industry: Drug Discovery Services

Partnerships

PfizerTakedaBiogen

Beyond the preview

Go deeper on LabCentral.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LabCentral.

Explore the full profile